In focus
Zuellig Pharma Buys Licensed Hangzhou Facility to Deepen Clinical Trial Sourcing in China
Zuellig Pharma has acquired a specialized clinical supply facility in Hangzhou, China, adding a Drug Distribution License to enable local sourcing of comparator drugs and concomitant medications for domestic and multi-regional trials.
Read the story